4//SEC Filing
Pearce Samantha 4
Accession 0001765581-25-000016
CIK 0001232524other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:35 PM ET
Size
6.9 KB
Accession
0001765581-25-000016
Insider Transaction Report
Form 4
Pearce Samantha
EVP, Chief Commercial Officer
Transactions
- Award
Ordinary Shares
2025-02-27+11,941→ 37,353 total - Award
Ordinary Shares
2025-02-27+5,778→ 43,131 total
Footnotes (2)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
- [F2]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001805688
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:35 PM ET
- Size
- 6.9 KB